3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
11
Neoplasms, Plasma Cell
3
Recurrence
1
Plasmacytoma
1
Paraproteinemias
1
Neoplasms
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Diseases
1
Corneal Diseases
1
Blood Protein Disorders
1
Interventions
silmitasertib
1
daratumumab
1
Leukapheresis
1
Drug Combinations
1
CF regimen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Plasmacytoma
×
daratumumab
×
Clear all
NCT04065308
2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2
Unknown
33 enrolled